JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB75839

Anti-Hck antibody [EP2415Y]

Be the first to review this product! Submit a review

|

(7 Publications)

Rabbit Recombinant Monoclonal HCK antibody. Suitable for WB and reacts with Human samples. Cited in 7 publications.

View Alternative Names

Tyrosine-protein kinase HCK, Hematopoietic cell kinase, Hemopoietic cell kinase, p59-HCK/p60-HCK, p59Hck, p61Hck, HCK

1 Images
Western blot - Anti-Hck antibody [EP2415Y] (AB75839)
  • WB

Lab

Western blot - Anti-Hck antibody [EP2415Y] (AB75839)

Blocking and diluting buffer and concentration : 5% NFDM/TBST. Exposure time : 1 second (Lane 1); 3 seconds (Lane 2).

All lanes:

Western blot - Anti-Hck antibody [EP2415Y] (ab75839) at 1/20000 dilution

Lane 1:

TF-1 (Human bone marrow erythroblast) whole cell lysate at 15 µg

Lane 2:

U-937 (Human histiocytic lymphoma monocyte) whole cell lysate at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

false

  • Carrier free

    Anti-Hck antibody [EP2415Y] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP2415Y

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This protein is known to be similar in amino acid sequence to LCK (P06239), FYN (P06241), YES1 (P07947), SRC (P12931), and LYN (P07948). Therefore, cross-reactivity with these homologous proteins may be observed. We would be happy to provide immunogen alignment information upon request, please contact our Scientific Support for further information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/20000", "WB-species-notes": "<p></p>" } } }

Product details

This product has switched from a hybridoma to recombinant production method on 13th September 2022.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Hck also known as Hemopoietic cell kinase is a protein with a mass of approximately 59-61 kDa. Hck belongs to the Src family of tyrosine kinases. It is expressed mainly in cells of the myeloid and B-lymphoid lineages such as macrophages neutrophils and certain B-cells. This protein functions as a non-receptor tyrosine kinase which means it's involved in adding phosphate groups to other proteins to modulate their activity. Such phosphorylation events play significant roles in signal transduction impacting cellular responses.
Biological function summary

Hck is involved in immune system regulation and cell signaling processes. It operates within complexes that facilitate its kinase activity and substrate specificity. Hck influences pathways that regulate immune cell responses like phagocytosis and cell migration. It helps in cellular adhesion and the production of reactive oxygen species both of which are vital for the proper functioning of myeloid cells in the immune response.

Pathways

Several signaling processes use Hck for transmitting signals from the outside of the cell to the inside. Hck participates in the Fc gamma receptor-mediated phagocytosis pathway and the chemokine signaling pathway. In these pathways Hck collaborates with proteins such as Src and Lyn enhancing the immune response and cellular communication. These pathways control important immune functions and cellular responses.

Hck has been implicated in certain cancers including myeloid leukemias where its overactivity can lead to uncontrolled cell proliferation. Additionally Hck plays a role in chronic inflammation seen in disorders like rheumatoid arthritis. In these conditions Hck interacts with other proteins such as Fgr and Yes exacerbating inflammation and disease progression. Understanding Hck's function offers insights into potential therapeutic targets for these health issues.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Non-receptor tyrosine-protein kinase found in hematopoietic cells that transmits signals from cell surface receptors and plays an important role in the regulation of innate immune responses, including neutrophil, monocyte, macrophage and mast cell functions, phagocytosis, cell survival and proliferation, cell adhesion and migration. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as FCGR1A and FCGR2A, but also CSF3R, PLAUR, the receptors for IFNG, IL2, IL6 and IL8, and integrins, such as ITGB1 and ITGB2. During the phagocytic process, mediates mobilization of secretory lysosomes, degranulation, and activation of NADPH oxidase to bring about the respiratory burst. Plays a role in the release of inflammatory molecules. Promotes reorganization of the actin cytoskeleton and actin polymerization, formation of podosomes and cell protrusions. Inhibits TP73-mediated transcription activation and TP73-mediated apoptosis. Phosphorylates CBL in response to activation of immunoglobulin gamma Fc region receptors. Phosphorylates ADAM15, BCR, ELMO1, FCGR2A, GAB1, GAB2, RAPGEF1, STAT5B, TP73, VAV1 and WAS.
See full target information HCK

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in pharmacology 16:1576884 PubMed40356975

2025

Optimization of neuron-specific interfering peptides targeting GABA receptor downregulation for proteolytic stability for conferring neuroprotection in a mouse model of cerebral ischemia.

Applications

Unspecified application

Species

Unspecified reactive species

Mohammad Hleihil,Musadiq A Bhat,Thomas Grampp,Dietmar Benke

Open life sciences 19:20220924 PubMed39247797

2024

Knockdown of HCK promotes HREC cell viability and inner blood-retinal barrier integrity by regulating the AMPK signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Lu Chen,Chengmin Lin

Nature communications 14:4297 PubMed37463911

2023

HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Man Chen,Madhav C Menon,Wenlin Wang,Jia Fu,Zhengzi Yi,Zeguo Sun,Jessica Liu,Zhengzhe Li,Lingyun Mou,Khadija Banu,Sui-Wan Lee,Ying Dai,Nanditha Anandakrishnan,Evren U Azeloglu,Kyung Lee,Weijia Zhang,Bhaskar Das,John Cijiang He,Chengguo Wei

Blood advances 7:2053-2065 PubMed36745103

2023

TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Teppei Sakoda,Yoshikane Kikushige,Toshihiro Miyamoto,Hidetoshi Irifune,Takuya Harada,Kiwamu Hatakeyama,Yuya Kunisaki,Koji Kato,Koichi Akashi

Cancers 14: PubMed35804926

2022

Genetic Disruption of the γ-Glutamylcysteine Ligase in PDAC Cells Induces Ferroptosis-Independent Cell Death In Vitro without Affecting In Vivo Tumor Growth.

Applications

Unspecified application

Species

Unspecified reactive species

Boutaina Daher,Willian Meira,Jerome Durivault,Celia Gotorbe,Jacques Pouyssegur,Milica Vucetic

Cancer immunology, immunotherapy : CII 71:1909-1921 PubMed35039904

2022

Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Fernanda Marconi Roversi,Maura Lima Pereira Bueno,Juliete Aparecida Francisco da Silva,Guilherme Rossi Assis-Mendonça,Cristiane Okuda Torello,Rodrigo Nato Shiraishi,Fernando Viera Pericole,Karla Priscila Ferro,Adriana Santos Silva Duarte,Eduardo Magalhães Rego,Sara Teresinha Olalla Saad

Frontiers in cell and developmental biology 9:634044 PubMed33842460

2021

Hematopoietic Cell Kinase (HCK) Is a Player of the Crosstalk Between Hematopoietic Cells and Bone Marrow Niche Through CXCL12/CXCR4 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Fernanda Marconi Roversi,Maura Lima Pereira Bueno,Fernando Viera Pericole,Sara Teresinha Olalla Saad
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com